China lymphoma specialist construction project launched

Lymphoma is one of the common malignant tumors.

On April 24, the Capacity Building and Continuing Education Center of the National Health Commission held the "Lymphoma Specialist Construction Project Launch Meeting" in Beijing.

Professor Ma Jun, director of the Harbin Institute of Hematology and Tumors and leader of the lymphoma specialist construction project expert group, said that in recent years, with the continuous innovation of treatment plans and the further coverage of medical insurance policies, the accessibility and affordability of treatment for lymphoma patients in China Significantly improved.

Professor Zhu Jun, Secretary of the Party Committee of Peking University Cancer Hospital and head of the clinical group of the Lymphoma Specialist Construction Project, said: “Lymphoma is a composite that takes into account the two characteristics of chronic disease and tumor.

Professor Li Xiaoqiu, deputy director of the Department of Pathology of the Tumor Hospital of Fudan University and leader of the pathology group of the Lymphoma Specialist Construction Project, said: “There are many types of lymphomas and the diagnosis is difficult.

The "Quality Control Standards for the Whole Process Management of Lymphoma Patients in China" released in 2020 under the promotion of Roche clarifies the concept of "the whole process management of lymphoma patients".

Yang Aiping, director of the National Health Commission’s Capacity Building and Continuing Education Center, said: “It is hoped that the project will focus on the grassroots, adhere to demand and problem-oriented, promote the standardization, standardization and systemization of continuing medical education, and continuously improve the competence of medical staff.